The role of urinary soluble endoglin in the diagnosis of pre‐eclampsia: comparison with soluble fms‐like tyrosine kinase 1 to placental growth factor ratio

Abstract

Objective Endoglin, an anti-angiogenic glycoprotein expressed on endothelial cells, has been proposed recently as a biomarker of pre-eclampsia (PE). Given that PE is characterised by an imbalance of angiogenic factors, we sought to determine the clinical utility of urinary soluble endoglin, relative to the soluble fms-like tyrosine kinase 1 to placental growth factor (PlGF) ratio, in the diagnosis of PE during gestation.Design Prospective observational cohort.Setting Tertiary referral university hospital.Population Two hundred and thirty-four pregnant women were enrolled prospectively in the following groups: healthy controls, n = 63; gestational age (GA), median (interquartile range), 33 weeks (27-39 weeks); chronic hypertension, n = 27; GA, 33 weeks (30-36 weeks); mild PE, n = 38; GA, 37 weeks (34-40 weeks); severe PE, n = 106; GA, 32 weeks (29-37 weeks).Methods Free urinary levels of soluble endoglin, soluble fms-like tyrosine kinase 1 and PlGF were measured by sensitive and specific immunoassay. Levels for all urinary analytes were normalised to creatinine.Main outcome measures Urinary soluble endoglin, and the soluble fms-like tyrosine kinase 1 to PlGF ratio.Results In healthy controls, urinary soluble endoglin levels were increased significantly at term relative to those earlier in gestation. Severe PE was characterised by an increased urinary level of soluble endoglin, soluble fms-like tyrosine kinase 1, protein to creatinine ratio and soluble fms-like tyrosine kinase 1 to PlGF ratio compared with all other groups. There was a direct correlation between urinary soluble endoglin and proteinuria that remained after GA correction (R = 0.382, P < 0.001). Urinary soluble endoglin could not differentiate mild PE from severe preterm PE. Overall, soluble endoglin had the ability to discriminate PE from chronic hypertension and healthy controls only in women who were evaluated at <37 weeks of GA. The sensitivity, specificity and accuracy of urinary soluble endoglin alone in the diagnosis of PE or in the identification of women with PE requiring a mandated delivery before 37 weeks of gestation were 70%, 86% and 76%, respectively. These values were inferior to those of the soluble fms-like tyrosine kinase 1 to PlGF ratio (P < 0.001). The addition of urinary soluble endoglin did not improve the diagnostic accuracy of the soluble fms-like tyrosine kinase 1 to PlGF ratio alone.Conclusions We have provided evidence that soluble endoglin is present and elevated in the urine of women who develop preterm PE. Urinary soluble endoglin has only limited ability to determine the severity of PE and to distinguish between PE and chronic hypertension both preterm and at term. Compared with urinary soluble endoglin, the soluble fms-like tyrosine kinase 1 to PlGF ratio remains a better marker of disease presence, severity and outcome.Keywords Biomarkers, endoglin, placental growth factor, soluble fms-like tyrosine kinase 1, urine.Please cite this paper as: Buhimschi C, Baumbusch M, Dulay A, Lee S, Wehrum M, Zhao G, Bahtiyar M, Pettk...

Redundant and Differential Roles of Transcription Factors Gli1 and Gli2 in the Development of Mouse Fetal Leydig Cells1

“…The Gli1 knockout animals in our colony developed normally and were fertile when they reached adulthood, consistent with the original observation [24]. At the time of birth, the reproductive organs in Gli1 and Gli2 knockout newborns were indistinguishable from their respective wild-type littermates (Fig.…”

Urine and serum concentrations of Cytokeratin 19 in preeclampsia

“…Of note in our study population 24 h urine samples all showed increased levels of protein excretion over 300 mg. In any case other urinary biomarkers, such as urinary soluble endoglin [23] and inhibin A [24] which have been shown to be elevated in women with PE, might be more favorable for further investigation. Furthermore proteomics-based characterization of urine samples is a very promising approach that has been shown to be of value in accurately diagnosing PE and discriminating it from other hypertensive proteinuric disease [25].…”

Elevation of Urinary Adipsin in Preeclampsia

“…For pregnancies that have a high risk to develop preeclampsia, based on clinical parameters or sFlt-1 and PIGF, [3][4][5][6] homebased self-monitoring of BP in combination with the adipsin strip test seems to be a feasible approach for early detection of the preeclampsia onset. Because of the easiness of the test conduction and result interpretation, it requires only a brief education for the test conductor.…”

“…It has been found that altered concentration of soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PIGF) can predict the occurrence of preeclampsia weeks before the appearance of the clinical symptoms. [3][4][5][6] Uterine artery Doppler studies that assess the pulsability index reveal increased uterine vascular resistance well before the preeclampsia clinical signs arise.…”

“…It has been found that altered concentration of soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PIGF) can predict the occurrence of preeclampsia weeks before the appearance of the clinical symptoms. [3][4][5][6] Uterine artery Doppler studies that assess the pulsability index reveal increased uterine vascular resistance well before the preeclampsia clinical signs arise.7 These predictive tests are valuable for identifying highrisk pregnant women but are incapable of conveniently monitoring the exact occurrence of the disease. In this study, we assumed that in preeclampsia a urinary protein that closely correlated with the 24-hour urine protein could be identified with advanced proteomics technologies and could be developed as a simple rapid assay for point-of-care use and for home monitoring as well.…”